Liminatus Pharma Operating Income 1971-1970 | LIMN

Liminatus Pharma operating income from 1971 to 1970. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Liminatus Pharma Annual Operating Income
(Millions of US $)
Liminatus Pharma Quarterly Operating Income
(Millions of US $)
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.000B $0.000B
Liminatus Pharma LLC operates as a clinical-stage immuno-oncology company which develops novel cancer therapies. Liminatus Pharma LLC is based in LA Palma, California.
Stock Name Country Market Cap PE Ratio
Flowco Holdings (FLOC) United States $2.052B 0.00
Oaktree Acquisition III Life Sciences (OACC) United States $0.233B 0.00
Aduro Clean Technologies (ADUR) Canada $0.178B 0.00
Range Capital Acquisition (RANG) United States $0.142B 0.00
Tavia Acquisition (TAVI) $0.141B 0.00
YSX Tech (YSXT) China $0.102B 0.00
CO2 Energy Transition (NOEM) United States $0.096B 0.00
Leishen Energy Holding (LSE) China $0.090B 0.00
YHN Acquisition I (YHNA) $0.082B 0.00
Youxin Technology (YAAS) China $0.042B 0.00
New Century Logistics (BVI) (NCEW) Hong Kong, SAR China $0.028B 0.00
Sky Quarry (SKYQ) United States $0.015B 0.00
PicoCELA (PCLA) Japan $0.011B 0.00
Hong Kong Pharma Digital Technology Holdings (HKPD) $0.010B 0.00
Smart Digital Group (SDM) $0.000B 0.00
Winchester Bancorp (WSBK) $0.000B 0.00
Yuanbao - (YB) China $0.000B 0.00
Cantor Equity Partners II (CEPT) $0.000B 0.00